Last reviewed · How we verify

Topical Lidocaine 4% Cream — Competitive Intelligence Brief

Topical Lidocaine 4% Cream (Topical Lidocaine 4% Cream) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic. Area: Anesthesia/Pain Management.

marketed Local anesthetic Voltage-gated sodium channels Anesthesia/Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Topical Lidocaine 4% Cream (Topical Lidocaine 4% Cream) — Children's Hospital of Philadelphia. Lidocaine blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses to produce local anesthesia.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Topical Lidocaine 4% Cream TARGET Topical Lidocaine 4% Cream Children's Hospital of Philadelphia marketed Local anesthetic Voltage-gated sodium channels
Liposomal Bupivacaine Liposomal Bupivacaine Wake Forest University Health Sciences marketed Local anesthetic Voltage-gated sodium channels
Active bupivacaine 0.375% PENG block Active bupivacaine 0.375% PENG block University of California, San Diego marketed Local anesthetic Voltage-gated sodium channels
Lidocaine %2 ampoule Lidocaine %2 ampoule Kaohsiung Medical University Chung-Ho Memorial Hospital marketed Local anesthetic Voltage-gated sodium channels
Non-buffered Anesthetic Non-buffered Anesthetic University Hospitals Cleveland Medical Center marketed Local anesthetic Voltage-gated sodium channels
Lidocaine HCl 0.8% in D5W Lidocaine HCl 0.8% in D5W Vanderbilt University Medical Center marketed Local anesthetic / Antiarrhythmic (Class IB) Voltage-gated sodium channels
Liposomal bupivacaine left injection Liposomal bupivacaine left injection Prisma Health-Upstate marketed Local anesthetic (amide) Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic class)

  1. University of California, San Diego · 3 drugs in this class
  2. Durect · 3 drugs in this class
  3. Pacira Pharmaceuticals, Inc · 3 drugs in this class
  4. Wake Forest University Health Sciences · 3 drugs in this class
  5. Medical University of Vienna · 3 drugs in this class
  6. Imperial College London · 2 drugs in this class
  7. Hvidovre University Hospital · 2 drugs in this class
  8. Innocoll · 2 drugs in this class
  9. George Washington University · 2 drugs in this class
  10. Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Topical Lidocaine 4% Cream — Competitive Intelligence Brief. https://druglandscape.com/ci/topical-lidocaine-4-cream. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: